| Market Cap | €723.6M | |
| Enterprise Value | — | |
| Revenue | €1.40B | −21.8% |
| Gross Profit | €1.23B | −22.3% |
| EBITDA | €266.6M | −48.2% |
| Net Income | -€1.48B | — |
| Diluted EPS | -€11.16 | — |
| Free Cash Flow | €246.9M | −74.8% |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend · 7y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | ||||||||||
| Gross Margin | 84.13% | 85.35% | 87.31% | 88.06% | 91.13% | 88.65% | 88.13% | 64% | 85% | |
| Operating Margin | −3.73% | 13.01% | 11.36% | −32.29% | 13.63% | −11.01% | −94.74% | 7% | 8% | |
| EBITDA Margin | 35.11% | 42.63% | 43.00% | 38.65% | 47.36% | 28.80% | 19.10% | 7% | 63% | |
| Net Margin | −7.88% | 4.64% | 3.72% | −27.24% | 6.86% | −13.64% | −105.70% | 7% | 8% | |
| FCF Margin | 32.19% | 39.56% | 30.05% | 35.35% | 22.17% | 54.89% | 17.69% | 7% | 80% | |
| FCFE Margin | 90.83% | 90.81% | 37.50% | 62.26% | 30.53% | 35.94% | −8.63% | 7% | 18% | |
| OCF Margin | 37.65% | 43.07% | 33.21% | 38.01% | 23.36% | 56.51% | 20.09% | 7% | 69% | |
| Gross Profitability | 37.22% | 38.86% | 37.42% | 34.21% | 40.94% | 34.29% | 31.17% | 7% | 51% | |
| Capex Intensity | 5.46% | 3.51% | 3.15% | 2.66% | 1.20% | 1.62% | 2.40% | 36% | 47% | |
| ▸Returns on Capital · 4 ratios | ||||||||||
| ▸DuPont factors (ROE drivers) · 2 ratios | ||||||||||
| ▸Earnings quality · 5 ratios | ||||||||||
| ▸Liquidity & coverage · 9 ratios | ||||||||||
| ▸Leverage · 6 ratios | ||||||||||
| ▸Working capital · 8 ratios | ||||||||||
| ▸Capital allocation · 1 ratios | ||||||||||
| ▸Other · 1 ratios | ||||||||||
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | €1.59B | €2.22B | €2.13B | €1.81B | €2.30B | €1.79B | €1.40B |
| YoY % | +39.4% | -4.4% | -14.6% | +26.8% | -22.4% | -21.8% | |
| Cost of Revenue | €253.1M | €325.7M | €269.7M | €216.6M | €204.2M | €202.7M | €165.7M |
| YoY % | +28.7% | -17.2% | -19.7% | -5.7% | -0.7% | -18.3% | |
| Gross Profit | €1.34B | €1.90B | €1.86B | €1.60B | €2.10B | €1.58B | €1.23B |
| YoY % | +41.5% | -2.2% | -13.9% | +31.2% | -24.5% | -22.3% | |
| R&D Expense | €720.8M | €827.1M | €822.5M | €1.44B | €1.07B | €1.07B | €1.88B |
| YoY % | +14.7% | -0.6% | +75.1% | -25.6% | 0.0% | +75.8% | |
| Selling & Marketing Expense | €386.6M | €442.8M | €412.6M | €343.2M | €413.3M | €387.7M | €268.1M |
| YoY % | +14.5% | -6.8% | -16.8% | +20.4% | -6.2% | -30.8% | |
| SG&A Expense | €193.0M | €228.4M | €270.2M | €301.5M | €291.1M | €267.9M | €288.1M |
| YoY % | +18.3% | +18.3% | +11.6% | -3.4% | -8.0% | +7.5% | |
| Operating Income | -€59.5M | €289.4M | €241.5M | -€585.8M | €313.6M | -€196.5M | -€1.32B |
| YoY % | -16.6% | ||||||
| Interest Expense | €18.1M | €18.4M | €24.5M | €36.0M | €74.8M | €106.3M | €89.2M |
| YoY % | +1.7% | +33.2% | +46.9% | +107.8% | +42.1% | -16.1% | |
| Equity Method Income | €0 | €0 | €0 | €0 | €0 | €0 | €0 |
| Income Tax | €45.7M | €132.6M | €113.6M | -€109.1M | €96.8M | -€17.3M | €127.8M |
| YoY % | +190.2% | -14.3% | |||||
| Net Income (incl. NCI) | -€124.2M | €105.2M | €79.5M | -€494.7M | €157.9M | -€243.2M | -€1.52B |
| YoY % | -24.4% | ||||||
| Minority Interest (P&L) | €1.4M | €2.1M | €400,000 | -€600,000 | €100,000 | €200,000 | -€41.3M |
| YoY % | +50.0% | -81.0% | +100.0% | ||||
| Net Income | -€125.6M | €103.1M | €79.1M | -€494.2M | €157.8M | -€243.5M | -€1.48B |
| YoY % | -23.3% | ||||||
| EPS (Basic) | -€1.12 | €0.87 | €0.66 | -€4.08 | €1.27 | -€1.92 | -€11.16 |
| YoY % | -24.1% | ||||||
| EPS (Diluted) | -€1.12 | €0.85 | €0.65 | -€4.08 | €1.24 | -€1.92 | -€11.16 |
| YoY % | -23.5% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
